New You Boot Camp Launch New Coastal Boot Camp

It is 2011 and time to shake off the January blues and shape up beside the seaside with the brand new Coastal Boot Camp, set on the stunning coast line of Cornwall and North Devon.

Fresh from the people behind New You Boot Camp – the most successful military style weight loss boot camp programme running in Europe – Coastal Boot Camp was developed due to customer demand for a boot camp that offers the same great results as the original programme but with more outdoor hiking and stunning motivational scenery.

The new Coastal Boot Camp programme also now includes additional extras of life coaching, nutrition and training one to ones, plus full access to an indoor swimming pool.

Coastal Boot Camp accommodation is set in 37 acres of unspoilt North Cornwall countryside with stunning panoramic views, comprising of a main Manor House and 3 converted and renovated traditional stone barns. Situated within a large private estate, beautiful beaches, coves and coastline are only a stone’s throw away and a plethora of magnificent woodland and coastal walks surround the camp, perfect for downtime in between rigorous military training to help participants relax and unwind.

As with all the New You Boot Camp programmes, a team of trained professional Military Physical Instructors have designed a robust military fitness course that puts everyone through their paces and targets those problem areas. However, Coastal Boot Camp not only pledges weight lose and a fabulous new figure but endeavours to leave everyone with a zest for the great outdoors, feeling invigorated and ready to take on the World!

Via EPR Network
More Healthcare press releases

Early Alcohol Consumption Predictor For Future Marital Woes

Indiana University School of Education conducted a study slated for publication in the April 20111 issue of Alcoholism: Clinical & Experimental Researchwhich indicates early alcohol use directly correlates to the age a person gets married.

In addition, the study suggests that those who are dependent on alcohol tend to have early separations once they are married.

“We’ve always known that alcohol dependence causes myriad problems,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “However, studies such as these further emphasize what we have said all along: alcoholism affects the lives of everyone with whom the alcoholic is involved. Alcohol use puts a strain on marriages financially, emotionally, mentally as well as socially. Every single aspect of an individuals’ life is impacted by alcoholism. Alcohol use of a potential spouse is certainly an important point to consider prior to making the decision to enter into such a serious commitment and, if you’re loved one needs alcoholism treatment, it’s best to know that from the outset.”

The Summary Health Statistics for U.S. Adults showed that 52% of adults, 18 years and older, were current regular drinkers, consuming at least 12 drinks in the past year. In addition, 13% of adults 18 years and older were infrequent drinkers, consuming 1-11 drinks in the past year. In addition, statistics for alcohol use tended to go down as a person got older.

Mountainside Drug Rehab and Alcohol Treatment Center specializes in helping the entire family and loved ones put back together their lives which have been affected by drug and alcohol abuse by offering comprehensive, compassionate programs in an environment conducive to healing. A key component of treatment is its Family Wellness Program.

Via EPR Network
More Healthcare press releases

Assay-Ready Chemistry Partnership between Molplex & Enamine

Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply services. The agreement is a major step towards eliminating the high start-up costs ofdrug discovery, bringing sophisticated drug design, compound management and assay-ready chemistry to the world’s drug discovery scientists on demand.

The agreement adds Molplex online drug design systems to the deep experience in organic chemistry and compound management of Enamine to solve the problem of generating viable chemical leads for novel targets.

Molplex CEO David E. Leahy said: “We are very proud to be selected by Enamine as their partner for on demand drug discovery services at a time when major restructuring of the industry is creating new opportunities and new markets for our combined expertise. This agreement marks a step change in the size and scope of our assay-ready chemical supply service and major progress towards our goal of being the world’s first choice partner for enabling the long tail of drug discovery”

Via EPR Network
More Healthcare press releases

Gene Therapy and Stem Cell Therapy Standard Developed For A Unique Derivative Of Post Hetero-Plastic Inplantation Chronic Inflammation Syndrome, The NIDO Disease

Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned organization under oversee of Department of Health & Human Services, reached once to share the exegetical impression officially pre-published concerning the understanding specific spectrum of symptoms covering boroad range of character usually complained and observed through chronic inflammation, granuloma, some types of lymphoma and various uncommon symptoms to let physician scientists suspecting indicium of neurological diseases, NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome and setting Massachusetts indications of treatments standardized manual (Massachusetts manual) & diagnostic and standardized medical treatment manual for post hetero-plastic inplantation chronic inflammation syndrome, specific edition against NIDO Disease.

The once defined causes of NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome are considered each of a common living organism to cause conformational diseases like Creutzfeldt-Jakob disease, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and kinds of and a set of biochemical and physical reaction and response realized by cross-species gene- mutation, as biotransformation, easily describing natural physiological and biochemical changes in vivo substrate of human bodies. After this studies, standardized protocol of gene therapy and applied stem cell therapy is now in practice and on available.

Faculties,committing themselves entirely to the project, of each institutes and organizations participating the project to ascertain proteins and DNA/genomic DNA/genom of human, other mammal and virulent microorganism including bacillus/virus affecting each symptom and the symptoms’ spectrum expressed generally and observed commonly on patients suffered from NIDO disease, extraordinarily unique derived type of post hetero-plastic implantation chronic inflammation syndrome and to develop diagnostic standard and treatment protocol standardized and to find a clue compose gene therapy protocol and applied stem cell therapy protocol to entirely heal NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome and to let all of current suffered patients from various combined symptoms directly derived by chronic inflammation and various tumors, have to express full surprise at the fact that these disease and patients suffered are made up and left no attention and no relief.

Via EPR Network
More Healthcare press releases

A Call For Tighter Non-Prescription Drug Regulation To Fight Meth Labs

In recent years, the FDA has begun implementing tighter regulations for medications that previously could be obtained easily, off the shelf at any drug store. Yet, many states are pushing for even tighter regulations of non-prescription medications, such as those used to treat colds and flu.

“Cold and flu medications are useful for their intended application, however they can be altered and used for illegal purposes,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “That’s the main reason that the FDA began monitoring the purchase of those substances. Individuals were buying these types of medication in large quantities and modifying them to manufacture illegal meth. Obviously, the tighter regulations have severely limited individuals’ ability to obtain these substances, however there will always be a way to circumnavigate almost any regulation. That’s why many states are considering legislature to require a physician’s prescription for these types of medications. Only time will tell if such measures will be passed and effective in combating the war on drugs and, particularly, meth labs.”

Abuse of any drug significantly alters how an individuals’ brain functions. Brain imaging studies have shown that chronic meth abuse results in reduced motor skills as well impaired verbal learning. In addition, many meth users experience significant emotional problems as a result of their abuse.

The NIDA cites the following statistics on methamphetamines:

•  It’s estimated that of all Americans 12 years and older, 10.4 million have tried meth at least once in their life

•  Over 15,000 deaths occur from stimulant use

•  Meth use contributed to over 8 percent of all drug-related Emergency Department admissions

Mountainside Drug Rehab and Alcohol Treatment Center is highly skilled in assisting families put their lives back together when affected by all types of substance abuse, including meth addictions. And, for the past 12 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get and to remain sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 12 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

New UN Program Will Ensure Developing Nations Continue to Have Access to Drugs Effective At Treating Malaria

Earlier this week, the United Nations announced a new plan of action designed to help fight disease resistance to artemisinin, the world’s most potent treatment for malaria. Launched by the UN World Health Organization (WHO) and the Roll Back Malaria Partnership (RBM), the groups hope to better contain and prevent resistance to artemisinins, the critical component of artemisinin-based combination therapies (ACTs), which are currently the most effective weapon in treating falciparum malaria.

The WHO’s announcement describes the plan as a five-step process which “aims to contain and prevent artemisinin resistance by stopping the spread of resistant parasites, increase monitoring and surveillance for artemisinin resistance, improve access to malaria diagnostic testing and rational treatment with ACTs, invest in artemisinin resistance-related research, and motivate action and mobilize resources.”

Global Health Progress is hopeful that this action plan will help to ensure that developing nations continue to have access to drugs that most effectively treat malaria. Many malaria-stricken countries lack the resources needed to keep an effective health care system running smoothly. Strong, effective health systems are vital to helping those in need of access to drugs, and health care improvements made today will strengthen the ability of countries to develop sustainable systems that can meet tomorrow’s challenges. Stopping the spread of drug-resistant strains of malaria and other diseases are essential to these goals.

Investing in local R&D capacity and national research systems is another way research-based biopharmaceutical companies help strengthen health systems. Local production can play a valuable role in building overall local capacity and enabling developing countries to increase access to essential medicines.

It is the responsibility of the entire international community to facilitate access to medicines. Success depends on all sectors working in partnership; not only to make medicines more accessible, but also to ensure continued innovation into new medicines for the treatment and prevention of all diseases.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector. www.globalhealthprogress.org;  twitter.com/globalhealthfacebook.com/pages/Global-Health-Progress/124850684219049;  linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

Next Genetic Natural Stem Cell Therapy Established

Division of Gene Medicine & Stem Cell Application, School of Medical Science, complete the research and established completely new protocol totally recovering natural bio mechanism of hair regrowth.

The researchers, led by Lord. Prof. Dr. Daichent Otto Rie, specified protein and genom to affect internal bio mechanism to generate hair and control the level of successful growth being low which is the baldness.

The key cast of the set of the bio cycle is hair follicles, which is stem cell on head skin and effect or holding function to cure many neurotic diseases and disorders like Alzheimer’s disease – Prion Disease and even Trion Disease (Post Hetero-Plastic Implantation Chronic Inflammation Syndrome; PhCIS) has absolutely unique character being retrieved absolute stem cell, which can recover the ability as stem cell after got adult. The key genom and DNA has been found through the Genom Project’s T-Protocol research developing in the government registered Genom Project since 2005. The most concentrated attention of researchers is not “what is cause” but “What protocol is best”.

The team of Prof.Daichent has successfully completed in vivo and in vivro experiment actually using voluntary patients whose types of hair loss being across over highly wide range extent to even lymphoma and cancer and finally established next genetic hair loss curing treatment protocol mainly composed of stem cell therapy and gene therapy.

Most of cases are treatable through entry level stem cell theraputic technique or HIV-1 Vector using high level technique but A20 introduction as gene therapy is required when treating patients being suffered from lymphoma, cancer or any neurotic diseases like Alzheimer’s disease – Prion Disease and even Trion Disease (Post Hetero-Plastic Implantation Chronic Inflammation Syndrome; PhCIS).

As Prof.Daichent points since 2005 being on School of Public Health of Harvard, in the treatment manual (published 2005), the key factor to overcome of lymphoma and chronic inflammation on human skin is extraordinary redundancy coding of polyglutamine DNA synthesis as the type of disease caused by pathological proteins and lack or heavy impairment of an specific DNA of A20.

Actually, the treatment protocol curing for baldness is also found through T-protocol which was essentially aimed at achieving causal and complete treatment of lymphoma, cancer, chronic inflammation and many neurotic diseases.

Via EPR Network
More Healthcare press releases

New England States Among Highest For Drug Abuse Occurrence

A 2009 study recently published by the Substance Abuse and Mental Health Services Administration shows that non-heroin drug abuse in the United States is highest within the New England states of the country.

Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island and Vermont were among the states with the highest abuse rates, with Maine topping the list.

“Admission rates for painkiller abuse rose over the nation,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center , a leading New Englandsubstance abuse treatment facility. “But, the highest rates of increase were seen within the New England states, particularly Maine. Since 2000, when the availability and effectiveness of such heavy-duty narcotics like Oxycontin and Fentnyl were discovered, abuse rates have skyrocketed. This is a red alert to clinicians to be vigilant in closely monitoring narcotic prescription use among their patients. Some New England states have a prescription monitoring program which tracks when an individual has a narcotic prescription filled. This measure is effective in helping doctors identify individuals who may be doctor shopping and getting multiple narcotics prescriptions filled. By sharing this information, doctors can take action to insure that they don’t fall prey to a drug abuser who is looking for an easy narcotic prescription.”

For the past 12 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get and to remain sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 12 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases